<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="365093">
  <stage>Registered</stage>
  <submitdate>3/10/2013</submitdate>
  <approvaldate>3/10/2013</approvaldate>
  <actrnumber>ACTRN12613001111763</actrnumber>
  <trial_identification>
    <studytitle>Assessment of  fat free mass in older adults: a comparison of body composition methods in an Asian and European population</studytitle>
    <scientifictitle>Validation of Bioelectrical Impedance Spectroscopy [BIS] for assessment of fat free mass in a Chinese Asian and European Caucasian adult population: comparison with dual energy x-ray absorptiometry (DeXA)</scientifictitle>
    <utrn />
    <trialacronym>VALBIO_Asia</trialacronym>
    <secondaryid>none</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Assessment of fat free mass</healthcondition>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Normal musculoskeletal and cartilage development and function</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Participants will undertake tests and measurements with 3 BIA/BIS devices (DF50, SFB7, SFB7mini prototype), DeXA, and pQCT.
All the measurements will be taken on one occassion
The approximated time is 1 hour to 1hr 15min
</interventions>
    <comparator>No control group</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Fat free mass (FFM) assessed by BIA/BIS, DeXA and pQCT.</outcome>
      <timepoint>Baseline</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Fat mass (FM) assessed by BIA/BIS, DeXA and pQCT.</outcome>
      <timepoint>Baseline</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>- Asian (Ethnic Chinese, mainland China, Hong Kong, Taiwanese), and
- Caucasian (Ethnic European)
- adult men and women; n=100 men, n=100 women; in both groups
- Aged 45-70 years
- 18-40kg/m2
- healthy, by self-report
</inclusivecriteria>
    <inclusiveminage>45</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>- significant current disease, including muscle wasting syndromes
- morbid obesity (BMI&gt;40kg/m2)
- presence of a cardiac pacemaker
- pregnancy
</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>True</patientregistry>
    <followup>0</followup>
    <followuptype>Weeks</followuptype>
    <purposeobs>Screening</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>7/10/2013</anticipatedstartdate>
    <actualstartdate>7/10/2013</actualstartdate>
    <anticipatedenddate />
    <actualenddate>6/06/2014</actualenddate>
    <samplesize>400</samplesize>
    <actualsamplesize>407</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Auckland</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Fonterra Co-operative Group Ltd</primarysponsorname>
    <primarysponsoraddress>9 Princes Street
Private Bag 92032
Auckland 1142</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Fonterra Co-operative Group Ltd</fundingname>
      <fundingaddress>9 Princes Street
Private Bag 92032
Auckland 1142
</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Background: The assessment of body composition is important to identify individuals at risk of muscle loss. Commercial bioelectrical impedence monitors are widely available, but provide only an indirect measure of fat free mass based on algorithms derived in Caucasian populations.
Objective: The objective of this study is to derive population specific predictive algorithms for the calculation of fat free mass and fat mass using a simple assessment device.
Design: This is a cross-sectional study, 400 participants, aged 45-70 years, of Asian Chinese (n=200) or Caucasian European (n=200) ethnicity will be recruited. Fat free mass (FFM) and fat mass (FM) will be measured on a single occasion using 3 BIA/BIS devices, DeXA and pQCT.
Findings: The findings from the study will enable rapid assessment of fat free mass in different target populations.</summary>
    <trialwebsite />
    <publication>Final report sent to sponsor and participants</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Northern A Health and Disability Ethics Committee</ethicname>
      <ethicaddress>Health and Disability Ethics Committee, Ministry of Health, C/- MEDSAFE, Level 6, Deloitte House, 10 Brandon Street, PO Box 5013, Wellington 6011</ethicaddress>
      <ethicapprovaldate>6/09/2013</ethicapprovaldate>
      <hrec>13/NTA/142</hrec>
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Sally Poppitt</name>
      <address>The University of Auckland
Private Bag 92019
Victoria Street West
Auckland 1142</address>
      <phone>+64 9 630 5160</phone>
      <fax />
      <email>s.poppitt@auckland.ac.nz</email>
      <country>New Zealand</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Wilson Yip</name>
      <address>The University of Auckland
Private Bag 92019
Victoria Street West
Auckland 1142</address>
      <phone>+64 9 630 3744</phone>
      <fax />
      <email>w.yip@auckland.ac.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Sally D Poppitt</name>
      <address>The University of Auckland
Private Bag 92019
Victoria Street West
Auckland 1142</address>
      <phone>+64 9 630 5160</phone>
      <fax />
      <email>s.poppitt@auckland.ac.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Wilson Yip</name>
      <address>The University of Auckland
Private Bag 92019
Victoria Street West
Auckland 1142</address>
      <phone>+64 9 630 5160</phone>
      <fax />
      <email>w.yip@auckland.ac.nz</email>
      <country>New Zealand</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>